Skip to main content
. 2016 Apr 12;6:24253. doi: 10.1038/srep24253

Table 1. Antiviral activity of Spirulina extract against influenza virus strains in vitro.

  EC50 (mg/mL) CC50 (mg/mL) SI
A/WSN/33(H1N1) 1.17 ± 0.09 23.80 20.34
A/TW/3446/2002(H3N2) 0.98 ± 0.24 23.80 24.28
B/TW/70555/2005 1.33 ± 0.15 23.80 17.89
A/TW/70058/2009(H1N1)* 1.17 ± 0.08 23.80 20.34
A/TW/147/2009(H1N1)* 0.98 ± 0.10 23.80 24.28
A/TW/126/2009(H1N1) 0.58 ± 0.02 23.80 41.03

EC50: 50% effective concentration, based on the inhibition of viral plaque formation.

CC50: 50% cytotoxic concentration, based on the MTT assay.

SI: selectivity index, a ratio of CC50 to EC50.

*Oseltamivir-resistant influenza strains.

All data represent mean ± SD for three independent experiments.